Clinical trial
Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic…
NCT00006220 · Washington University School of Medicine, Other · Terminated
Key facts
| NCT number | NCT00006220 |
|---|---|
| Title | Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy |
| Official title | Arsenic Trioxide Alone or With ATRA (Vesanoid) for Resistant Hematologic Malignancy |
| Lead sponsor | Washington University School of Medicine, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | arsenic trioxide, tretinoin |
| Enrollment | 5 |
| Start date | Jun 1, 1999 |
| Primary completion | Nov 1, 2000 |
| Completion | Feb 1, 2002 |
| First posted | May 20, 2004 |
| Last update posted | Feb 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: